{
    "id": "NGN_SA_AKI_Management_BATCH-300-147-1771349663340",
    "seed": "BATCH-300-147-1771349663340",
    "topic": "AKI Management",
    "type": "selectAll",
    "difficulty": 4,
    "cjmmStep": "Take Actions",
    "question": "A 68-year-old male client with a history of type 2 diabetes and hypertension was admitted for sepsis secondary to pneumonia. Over the past 48 hours, the client's urine output has decreased significantly. The nurse reviews the client's morning laboratory results and completes a focused assessment. Which actions should the nurse implement based on the provided clinical data? Select all that apply.",
    "exhibits": [
        {
            "name": "Provider's Orders",
            "type": "text",
            "content": "Admit to medical-surgical unit\nVital signs every 4 hours\nTelemetry monitoring\nRegular diet, low sodium\nStrict intake and output\nDaily weights\nIV 0.9% Sodium Chloride at 50 mL/hr\nCeftriaxone 1g IV every 12 hours\nLisinopril 10 mg PO daily\nMetformin 500 mg PO BID\nSodium polystyrene sulfonate 15 g PO once, now"
        },
        {
            "name": "Assessment and Lab Data",
            "type": "chart",
            "data": {
                "Assessment Findings": {
                    "Time": "0800",
                    "Neurological": "Alert and oriented x3, complains of fatigue.",
                    "Cardiovascular": "S1, S2 audible. Heart rate 98/min, irregular. BP 152/90 mmHg. +2 pitting edema bilateral lower extremities.",
                    "Respiratory": "Respirations 22/min, shallow. Fine crackles noted in bilateral lung bases.",
                    "Gastrointestinal/Genitourinary": "Bowel sounds active. Total urine output in last 8 hours: 100 mL.",
                    "Skin": "Warm, dry, pale."
                },
                "Laboratory Results": {
                    "Potassium": "6.1 mEq/L (3.5-5.0 mEq/L)",
                    "Sodium": "134 mEq/L (136-145 mEq/L)",
                    "BUN": "78 mg/dL (10-20 mg/dL)",
                    "Creatinine": "4.2 mg/dL (0.6-1.2 mg/dL)",
                    "Glucose": "145 mg/dL (70-110 mg/dL)"
                }
            }
        }
    ],
    "options": [
        {
            "id": "opt_3",
            "label": "Increase the IV fluid rate to 125 mL/hr.",
            "isCorrect": false
        },
        {
            "id": "opt_2",
            "label": "Request a dietary consult for a low-potassium, low-protein diet.",
            "isCorrect": true
        },
        {
            "id": "opt_1",
            "label": "Administer sodium polystyrene sulfonate as prescribed.",
            "isCorrect": true
        },
        {
            "id": "opt_5",
            "label": "Ensure the client is on continuous cardiac monitoring.",
            "isCorrect": true
        },
        {
            "id": "opt_6",
            "label": "Withhold the client's metformin.",
            "isCorrect": true
        },
        {
            "id": "opt_4",
            "label": "Administer the scheduled dose of lisinopril.",
            "isCorrect": false
        }
    ],
    "answerBreakdown": {
        "correct": [
            "opt_1",
            "opt_2",
            "opt_5",
            "opt_6"
        ],
        "rationales": {
            "opt_1": {
                "point": "The client's potassium level is critically high at 6.1 mEq/L. Sodium polystyrene sulfonate is a potassium-binding resin that helps excrete potassium from the body through the gastrointestinal tract. Administering this medication is a priority action to treat life-threatening hyperkalemia.",
                "distractor": ""
            },
            "opt_2": {
                "point": "The client has hyperkalemia, azotemia (high BUN), and AKI. A dietary consult is necessary to implement restrictions appropriate for renal failure, which typically include limiting potassium, phosphorus, sodium, and protein to reduce metabolic waste and electrolyte imbalances.",
                "distractor": ""
            },
            "opt_3": {
                "point": "",
                "distractor": "This action is incorrect and potentially harmful. The client is showing clear signs of fluid volume overload (pitting edema, crackles in the lungs) and is in the oliguric phase of AKI (100 mL urine in 8 hours). Increasing IV fluids would exacerbate fluid retention, worsen pulmonary edema, and strain the cardiovascular system."
            },
            "opt_4": {
                "point": "",
                "distractor": "Lisinopril, an ACE inhibitor, can decrease glomerular filtration pressure, potentially worsening renal function in AKI. It is also contraindicated in clients with hyperkalemia as it can further increase potassium levels. The nurse should question this order with the provider."
            },
            "opt_5": {
                "point": "Hyperkalemia (K+ 6.1 mEq/L) is a medical emergency because it increases the risk of life-threatening cardiac dysrhythmias and cardiac arrest. The client's heart rate is already irregular. Continuous cardiac monitoring is essential to detect any changes in cardiac rhythm promptly.",
                "distractor": ""
            },
            "opt_6": {
                "point": "Metformin is excreted primarily by the kidneys. In a client with significant renal impairment (Creatinine 4.2 mg/dL), metformin can accumulate and lead to lactic acidosis, a serious and potentially fatal complication. Therefore, it is contraindicated and must be withheld.",
                "distractor": ""
            }
        }
    }
}